TY - JOUR
T1 - Staged vs Complete Repair in Tetralogy of Fallot With Pulmonary Atresia
AU - Collaborative Research from the Pediatric Cardiac Intensive Care Society (CoRe-PCICS) Investigators
AU - Boucek, Katerina
AU - Mastropietro, Christopher W.
AU - Beall, Jonathan
AU - Keller, Everette
AU - Beshish, Asaad
AU - Flores, Saul
AU - Chlebowski, Meghan
AU - Yates, Andrew R.
AU - Choudhury, Tarif A.
AU - Mueller, Dana
AU - Kwiatkowski, David M.
AU - Migally, Karl
AU - Karki, Karan
AU - Willett, Renee
AU - Radman, Monique R.
AU - Reddy, Chetana
AU - Piggott, Kurt
AU - Capone, Christine A.
AU - Kapileshwarkar, Yamini
AU - Vijayakumar, Niranjan
AU - Prentice, Elizabeth
AU - Narasimhulu, Sukumar Suguna
AU - Martin, Renee H.
AU - Costello, John M
N1 - Funding Information:
This study was supported by a generous grant from the Emerson Rose Heart Foundation .
Publisher Copyright:
© 2023
PY - 2023/6
Y1 - 2023/6
N2 - Background: We sought to compare outcomes for infants with tetralogy of Fallot with pulmonary atresia (TOF/PA) and confluent pulmonary arteries who underwent staged or primary complete surgical repair. Methods: This retrospective study included infants undergoing initial surgical intervention between 0 and 60 days of age with TOF/PA without aortopulmonary collaterals from 2009 to 2018 at 20 centers. The primary outcome was days alive and out of the hospital in the first year of life (DAOH365). Secondary outcomes were mortality at 1 year of age and a composite major complication outcome. Multivariable modeling with generalized estimating equations were used to compare outcomes between groups. Results: Of 221 subjects, 142 underwent staged repair and 79 underwent primary complete repair. There was no significant difference in median DAOH365 between the staged and primary repair groups (317 days [interquartile range, 278-336] vs 338 days [interquartile range, 314-348], respectively; adjusted P =.13). Nine staged repair patients (7%) died in the first year of life vs 5 primary repair patients (6%; adjusted odds ratio, 1.00; 95% CI, 0.25-3.95). At least 1 major complication occurred in 37% of patients who underwent staged repair vs 41% of patients who underwent primary complete repair (P =.75), largely driven by the need for unplanned cardiac reinterventions. Conclusions: For infants with TOF/PA with confluent pulmonary arteries, a surgical strategy of staged or primary complete repair resulted in statistically similar DAOH365, early mortality, and morbidity.
AB - Background: We sought to compare outcomes for infants with tetralogy of Fallot with pulmonary atresia (TOF/PA) and confluent pulmonary arteries who underwent staged or primary complete surgical repair. Methods: This retrospective study included infants undergoing initial surgical intervention between 0 and 60 days of age with TOF/PA without aortopulmonary collaterals from 2009 to 2018 at 20 centers. The primary outcome was days alive and out of the hospital in the first year of life (DAOH365). Secondary outcomes were mortality at 1 year of age and a composite major complication outcome. Multivariable modeling with generalized estimating equations were used to compare outcomes between groups. Results: Of 221 subjects, 142 underwent staged repair and 79 underwent primary complete repair. There was no significant difference in median DAOH365 between the staged and primary repair groups (317 days [interquartile range, 278-336] vs 338 days [interquartile range, 314-348], respectively; adjusted P =.13). Nine staged repair patients (7%) died in the first year of life vs 5 primary repair patients (6%; adjusted odds ratio, 1.00; 95% CI, 0.25-3.95). At least 1 major complication occurred in 37% of patients who underwent staged repair vs 41% of patients who underwent primary complete repair (P =.75), largely driven by the need for unplanned cardiac reinterventions. Conclusions: For infants with TOF/PA with confluent pulmonary arteries, a surgical strategy of staged or primary complete repair resulted in statistically similar DAOH365, early mortality, and morbidity.
UR - http://www.scopus.com/inward/record.url?scp=85149990368&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149990368&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2023.01.029
DO - 10.1016/j.athoracsur.2023.01.029
M3 - Article
C2 - 36739070
AN - SCOPUS:85149990368
SN - 0003-4975
VL - 115
SP - 1463
EP - 1468
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 6
ER -